HighTower Advisors
ELV icon

HighTower Advisors’s Elevance Health ELV Stock Holding History

HighTower Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4
Closed -$17K – 3320
2022
Q1 		$17K Buy
+4
New +$1.83K ﹤0.01% 3180

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

HighTower Advisors's ELV Position: Q2 2026 in Review

HighTower Advisors reduced its Elevance Health (ELV) stake by 6.7% in Q2 2026, selling an estimated $862K and leaving 32,278 shares worth $12.5M. The position accounts for 0.01% of the portfolio, ranked #838.

HighTower Advisors first reported a position in ELV in Q3 2013 and has held it in 50 quarters since. The position peaked at $49.2M in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • HighTower Advisors held 32,278 shares of Elevance Health worth $12.5M as of Q2 2026.
  • HighTower Advisors sold 2,325 Elevance Health shares in Q2 2026, an estimated $862K.
  • Elevance Health made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #838 holding.
  • HighTower Advisors first reported a position in Elevance Health in Q3 2013 and has held it in 50 quarters since.
  • HighTower Advisors's Elevance Health position peaked at $49.2M in Q2 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.